Stockreport

Vertex passes key test In quest to treat kidney diseases [CNBC]

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
PDF Key Points The drug, povetacicept, is a central piece of the company's plan to expand into kidney disease. Vertex has faced questions about how it would diversify b [Read more]